{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:52:02Z","timestamp":1790070722060,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,3,6]]},"DOI":"10.1038\/onc.2013.72","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T10:24:25Z","timestamp":1364811865000},"page":"1249-1257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["CTSL2 is a pro-apoptotic target of E2F1 and a modulator of histone deacetylase inhibitor and DNA damage-induced apoptosis"],"prefix":"10.1038","volume":"33","author":[{"given":"C H","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"key":"BFonc201372_CR1","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.biocel.2009.06.004","volume":"41","author":"Z Wu","year":"2009","unstructured":"Wu Z, Zheng S, Yu Q . The E2F family and the role of E2F1 in apoptosis. Int J Biochem Cell Biol 2009; 41: 2389\u20132397.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFonc201372_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ceb.2007.10.006","volume":"19","author":"PJ Iaquinta","year":"2007","unstructured":"Iaquinta PJ, Lees JA . Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 2007; 19: 649\u2013657.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc201372_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tcb.2008.08.003","volume":"18","author":"S Polager","year":"2008","unstructured":"Polager S, Ginsberg D . E2F\u2014at the crossroads of life and death. Trends Cell Biol 2008; 18: 528\u2013535.","journal-title":"Trends Cell Biol"},{"key":"BFonc201372_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature03098","volume":"432","author":"SW Lowe","year":"2004","unstructured":"Lowe SW, Cepero E, Evan G . Intrinsic tumour suppression. Nature 2004; 432: 307\u2013315.","journal-title":"Nature"},{"key":"BFonc201372_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0014-5793(02)03270-2","volume":"529","author":"D Ginsberg","year":"2002","unstructured":"Ginsberg D . E2F1 pathways to apoptosis. FEBS Lett 2002; 529: 122\u2013125.","journal-title":"FEBS Lett"},{"key":"BFonc201372_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2007.11.031","volume":"13","author":"TC Hallstrom","year":"2008","unstructured":"Hallstrom TC, Mori S, Nevins JR . An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 2008; 13: 11\u201322.","journal-title":"Cancer Cell"},{"key":"BFonc201372_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccr.2007.12.017","volume":"13","author":"BD Dynlacht","year":"2008","unstructured":"Dynlacht BD . Live or let die: E2F1 and PI3K pathways intersect to make life or death decisions. Cancer Cell 2008; 13: 1\u20132.","journal-title":"Cancer Cell"},{"key":"BFonc201372_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1582-4934.2007.00030.x","volume":"11","author":"BM Putzer","year":"2007","unstructured":"Putzer BM . E2F1 death pathways as targets for cancer therapy. J Cell Mol Med 2007; 11: 239\u2013251.","journal-title":"J Cell Mol Med"},{"key":"BFonc201372_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/25867","volume":"395","author":"S Bates","year":"1998","unstructured":"Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL et al. p14ARF links the tumour suppressors RB and p53. Nature 1998; 395: 124\u2013125.","journal-title":"Nature"},{"key":"BFonc201372_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/82617","volume":"26","author":"T Stiewe","year":"2000","unstructured":"Stiewe T, Putzer BM . Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 2000; 26: 464\u2013469.","journal-title":"Nat Genet"},{"key":"BFonc201372_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/35036614","volume":"407","author":"M Irwin","year":"2000","unstructured":"Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000; 407: 645\u2013648.","journal-title":"Nature"},{"key":"BFonc201372_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/35078527","volume":"3","author":"MC Moroni","year":"2001","unstructured":"Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001; 3: 552\u2013558.","journal-title":"Nat Cell Biol"},{"key":"BFonc201372_CR13","doi-asserted-by":"publisher","first-page":"10508","DOI":"10.1074\/jbc.M512719200","volume":"281","author":"J Tan","year":"2006","unstructured":"Tan J, Zhuang L, Jiang X, Yang KK, Karuturi KM, Yu Q . Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity. J Biol Chem 2006; 281: 10508\u201310515.","journal-title":"J Biol Chem"},{"key":"BFonc201372_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ncb868","volume":"4","author":"Z Nahle","year":"2002","unstructured":"Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 2002; 4: 859\u2013864.","journal-title":"Nat Cell Biol"},{"key":"BFonc201372_CR15","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1074\/jbc.M312866200","volume":"279","author":"T Hershko","year":"2004","unstructured":"Hershko T, Ginsberg D . Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 2004; 279: 8627\u20138634.","journal-title":"J Biol Chem"},{"key":"BFonc201372_CR16","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1073\/pnas.0505585102","volume":"102","author":"Y Zhao","year":"2005","unstructured":"Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q . Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 2005; 102: 16090\u201316095.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201372_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/sj.gt.3301235","volume":"7","author":"BM Putzer","year":"2000","unstructured":"Putzer BM, Stiewe T, Crespo F, Esche H . Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy. Gene Ther 2000; 7: 1317\u20131325.","journal-title":"Gene Ther"},{"key":"BFonc201372_CR18","first-page":"1833","volume":"15","author":"WC Lin","year":"2001","unstructured":"Lin WC, Lin FT, Nevins JR . Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001; 15: 1833\u20131844.","journal-title":"Genes Dev"},{"key":"BFonc201372_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ncb998","volume":"5","author":"N Pediconi","year":"2003","unstructured":"Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L et al. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol 2003; 5: 552\u2013558.","journal-title":"Nat Cell Biol"},{"key":"BFonc201372_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ccr.2008.04.019","volume":"13","author":"X Jiang","year":"2008","unstructured":"Jiang X, Tan J, Li J, Kivimae S, Yang X, Zhuang L et al. DACT3 is an epigenetic regulator of Wnt\/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 2008; 13: 529\u2013541.","journal-title":"Cancer Cell"},{"key":"BFonc201372_CR21","doi-asserted-by":"publisher","first-page":"e46749","DOI":"10.1371\/journal.pone.0046749","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Yang ND, Zhou F, Shen T, Duan T, Zhou J et al. (-)-Epigallocatechin-3-Gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells via ROS-Mediated lysosomal membrane permeabilization. PLoS One 2012; 7: e46749.","journal-title":"PLoS One"},{"key":"BFonc201372_CR22","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1189\/jlb.0506359","volume":"81","author":"R Blomgran","year":"2007","unstructured":"Blomgran R, Zheng L, Stendahl O . Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J Leukoc Biol 2007; 81: 1213\u20131223.","journal-title":"J Leukoc Biol"},{"key":"BFonc201372_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrd2133","volume":"5","author":"JE Bolden","year":"2006","unstructured":"Bolden JE, Peart MJ, Johnstone RW . Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5: 769\u2013784.","journal-title":"Nat Rev Drug Discov"},{"key":"BFonc201372_CR24","first-page":"1624","volume":"58","author":"I Santamaria","year":"1998","unstructured":"Santamaria I, Velasco G, Cazorla M, Fueyo A, Campo E, Lopez-Otin C . Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res 1998; 58: 1624\u20131630.","journal-title":"Cancer Res"},{"key":"BFonc201372_CR25","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.biochi.2010.03.014","volume":"92","author":"L Sevenich","year":"2010","unstructured":"Sevenich L, Hagemann S, Stoeckle C, Tolosa E, Peters C, Reinheckel T . Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice. Biochimie 2010; 92: 1674\u20131680.","journal-title":"Biochimie"},{"key":"BFonc201372_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0076-6879(08)01409-2","volume":"442","author":"S Ivanova","year":"2008","unstructured":"Ivanova S, Repnik U, Bojic L, Petelin A, Turk V, Turk B . Lysosomes in apoptosis. Methods Enzymol 2008; 442: 183\u2013199.","journal-title":"Methods Enzymol"},{"key":"BFonc201372_CR27","doi-asserted-by":"publisher","first-page":"19140","DOI":"10.1074\/jbc.M802513200","volume":"283","author":"G Droga-Mazovec","year":"2008","unstructured":"Droga-Mazovec G, Bojic L, Petelin A, Ivanova S, Romih R, Repnik U et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem 2008; 283: 19140\u201319150.","journal-title":"J Biol Chem"},{"key":"BFonc201372_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/sj.cdd.4401333","volume":"11","author":"M Jaattela","year":"2004","unstructured":"Jaattela M, Cande C, Kroemer G . Lysosomes and mitochondria in the commitment to apoptosis: a potential role for cathepsin D and AIF. Cell Death Differ 2004; 11: 135\u2013136.","journal-title":"Cell Death Differ"},{"key":"BFonc201372_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/cdd.2009.162","volume":"17","author":"ZL Wu","year":"2010","unstructured":"Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY, Yu Q . Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ 2010; 17: 801\u2013810.","journal-title":"Cell Death Differ"},{"key":"BFonc201372_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrd772","volume":"1","author":"RW Johnstone","year":"2002","unstructured":"Johnstone RW . Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002; 1: 287\u2013299.","journal-title":"Nat Rev Drug Discov"},{"key":"BFonc201372_CR31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1101\/gad.1524107","volume":"21","author":"J Tan","year":"2007","unstructured":"Tan J, Yang X, Zhuang L, Jiang X, Chen W, Lee PL et al. Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev 2007; 21: 1050\u20131063.","journal-title":"Genes Dev"},{"key":"BFonc201372_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ncb2171","volume":"13","author":"PA Kreuzaler","year":"2011","unstructured":"Kreuzaler PA, Staniszewska AD, Li W, Omidvar N, Kedjouar B, Turkson J et al. Stat3 controls lysosomal-mediated cell death in vivo. Nat Cell Biol 2011; 13: 303\u2013309.","journal-title":"Nat Cell Biol"},{"key":"BFonc201372_CR33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/cdd.2009.162","volume":"17","author":"ZL Wu","year":"2010","unstructured":"Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY, Yu Q . Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ 2010; 17: 801\u2013810.","journal-title":"Cell Death Differ"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201372","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:04:57Z","timestamp":1647889497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,3,6]]}},"alternative-id":["BFonc201372"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.72","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]},"assertion":[{"value":"26 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}